| | 
Part, Chapter, Paragraph
1 II, 5. 1. 1| cirrhosis and other chronic liver diseases; nephrological
2 II, 5. 1. 1| after 10 months of age.~Liver Cirrhosis~The patterns in
3 II, 5. 5. 3| use of nicotine) or the liver (due to alcohol consumption).
4 II, 5. 12 | 5.12. Liver cirrhosis~ ~
5 II, 5. 12. 1| of HBV and HCV in causing liver cirrhosis, this Chapter
6 II, 5. 12. 3| bleeding, better control of liver functions and liver transplantation –
7 II, 5. 12. 3| control of liver functions and liver transplantation – may also
8 II, 5. 12. 3| cirrhosis of deaths from acute liver intoxication or failure (
9 II, 5. 12. 3| subjects with cirrhotic liver; further attention to diagnosis
10 II, 5. 12. 3| certification validity from liver disease is therefore required.~ ~ ~
11 II, 5. 12. 5| cirrhosis and other chronic liver diseases is based on the
12 II, 5. 12. 6| provided by the introduction of liver transplantation.~ ~The impact
13 II, 5. 12. 6| long-term prognosis after liver transplantation and the
14 II, 5. 12. 6| proportion of cirrhosis cases, liver transplantation is performed
15 II, 5. 12. 6| identification and diagnosis of liver cancer foci. Thus, at least
16 II, 5. 12. 6| transplantation on chronic liver disease would be attributed
17 II, 5. 12. 6| disease would be attributed to liver cancer following cirrhosis,
18 II, 5. 12. 6| itself.~ ~A wider adoption of liver transplantation in the future
19 II, 5. 12. 7| future burden of chronic liver disease in the United States.
20 II, 5. 12. 7| Decarli A (1997): Trends of liver cirrhosis mortality in Europe,
21 II, 5. 12. 7| the risk of symptomatic liver cirrhosis. Hepatology 27:
22 II, 5. 12. 7| trends in mortality from liver cirrhosis, 1955 to 1990.
23 II, 5. 12. 7| DA, McCambridge J (2006): Liver cirrhosis mortality rates
24 II, 5. 12. 7| Evaluation of efficacy of liver transplantation in alcoholic
25 II, 5. 12. 7| alcohol consumption and liver cirrhosis mortality in 14
26 II, 5. 12. 7| Schuppan D, Afdhal NH (2008): Liver Cirrhosis. Lancet 371: 838–
27 II, 5. 12. 7| three decades in Italy. Dig Liver Dis 37:622-627.~ ~World
28 II, 6. 3. 3| B is an infection of the liver caused by hepatitis B virus (
29 II, 6. 3. 3| chronically infected can develop liver cirrhosis (25%) or cancer (
30 II, 6. 3. 3| of those go on to develop liver cirrhosis or cancer. Injecting
31 II, 6. 3. 6| is a viral disease of the liver caused by hepatitis A virus (
32 II, 9. 3. 1| prostate, testis, bowel, liver, kidney, oesophagus and
33 II, 9. 3. 1| was responsible for 30% of liver transplants in Europe (European
34 III, 10. 2. 1| cavities~- Nasal sinuses~- Liver~- Chronic obstructive pulmonary
35 III, 10. 2. 1| alcohol increases the risk of liver cirrhosis and acute and
36 III, 10. 2. 1| reduction (almost 3 times) of liver cirrhosis (Figure 10.2.1.
37 III, 10. 2. 1| larynx (upper airway), liver and female breast, and -
38 III, 10. 2. 1| causes:~- 45,000 deaths from liver cirrhosis~- 50,000 cancer
39 III, 10. 2. 1| accidents), stroke and liver disease (across the EU15),
40 III, 10. 2. 1| this to be mainly due to liver cirrhosis and alcohol-related
41 III, 10. 2. 1| reductions in deaths from liver cirrhosis, mortality rates
42 III, 10. 2. 1| ultraviolet light and completed in liver and kidney. Therefore, under
43 III, 10. 4. 2| products~ ~Effects on the liver,~thyroid, immune system~
44 III, 10. 4. 2| chunks in~animal feed~ ~Liver cancer (in~combination with~
45 III, 10. 4. 2| combination with~hepatitis) Liver~abnormalities, tumours~genotoxic
46 III, 10. 4. 2| Possible oesophageal~and liver cancer~ ~In preparation~
47 III, 10. 4. 2| herbal teas~Effects in the liver,~carcinogenic~ ~NL; EU in
48 IV, 11. 5. 1| failure of organs such as the liver, lung and heart, it is the
49 IV, 11. 5. 1| expanding to the field of liver, heart, lung and tissue
50 IV, 11. 5. 2| ERA-EDTA Registry: htt European Liver Transplant Registry: htt
51 IV, 11. 5. 2| Registry (REDMO): ht Spanish Liver Transplant Registry: htt
52 IV, 11. 5. 4| while waiting for a heart, liver or lung transplant usually
53 IV, 11. 5. 4| transplant activity and 5% of liver transplantation. Although
54 IV, 11. 5. 6| document~1997Recom 16 on liver transplantation from living
55 IV, 12. 2 | reductions in deaths from liver cirrhosis, fatality rates
56 IV, 13. 7 | treatment for end-stage renal, liver, lung and heart failure.~ ~
57 Key, Ap5. 0. 0| Lithuania~live-birth~live-births~liver~longevity~Luxembourg~lymphogranuloma~
|
|
| |
